Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

CAS 141-97-9

ethyl 3-oxobutanoate1-Ethoxybutane-1,3-dione

登记编号PALB-027、(XXXVI)1024528-1-d、SITAF-014、SUNT-012

应用背景(按来源药适应症)

乳腺癌哌柏西利非小细胞肺癌普拉替尼甲状腺瘤普拉替尼甲状腺髓样癌普拉替尼膀胱炎西他沙星鼻窦炎西他沙星扁桃体炎西他沙星肺炎西他沙星宫颈炎西他沙星冠周炎西他沙星胰腺神经内分泌肿瘤苹果酸舒尼替尼肾细胞癌苹果酸舒尼替尼胃肠道间质瘤苹果酸舒尼替尼骨肉瘤苹果酸舒尼替尼肉瘤苹果酸舒尼替尼淋巴瘤苹果酸舒尼替尼

来源药(使用该中间体的合成路线)

品种梯队到期年
哌柏西利PalbociclibTier A · 立即攻坚2027
普拉替尼PralsetinibTier C · 观察 / 贸易2031
西他沙星Sitafloxacin HydrateTier C · 观察 / 贸易-
苹果酸舒尼替尼Sunitinib MalateTier B · 提前布局-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

普拉替尼优化路线步数:6总收率:/

本站可供应的对应中间体

同 CAS 多家在售供应横向对比;价格区间为供应方挂牌口径,实价以询价确认为准。

供应商产品价格区间最小起订货期资质
Qualified Partner — East China API Works5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP Site2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
询价询价询价
Unibest Taizhou GMP-like Site6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Pharmaceutical Intermediates
询价询价询价
Qualified Partner — East China API Workstert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP SiteTert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
询价询价询价
Unibest Taizhou GMP-like Sitetert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
询价询价询价
Qualified Partner — East China API WorksPD 0332991 HCl
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP SiteCarbamic acid, (7S)-5-azaspiro[2.4]hept-7-yl-, 1,1-dimethylethyl ester (9CI)
Pharmaceutical Intermediates
询价询价询价
Qualified Partner — East China API Works5-Fluoro-2-oxindole
Pharmaceutical Intermediates
询价询价询价
Unibest Nantong cGMP Site5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
Pharmaceutical Intermediates
询价询价询价

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。